These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19412567)

  • 1. Significance of lymph node metastasis in patients with colorectal cancer peritoneal carcinomatosis.
    Chua TC; Yan TD; Ng KM; Zhao J; Morris DL
    World J Surg; 2009 Jul; 33(7):1488-94. PubMed ID: 19412567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph nodes ratio is associated with the survival of colorectal cancer patients with peritoneal carcinomatosis.
    Matsuda K; Hotta T; Takifuji K; Kobayashi Y; Tsuji T; Nagai Y; Horiuchi T; Yamaue H
    Am Surg; 2011 May; 77(5):602-7. PubMed ID: 21679595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin.
    Cao C; Yan TD; Black D; Morris DL
    Ann Surg Oncol; 2009 Aug; 16(8):2152-65. PubMed ID: 19434455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian metastasis is associated with retroperitoneal lymph node relapses in women treated for colorectal peritoneal carcinomatosis.
    Eveno C; Goéré D; Dartigues P; Honoré C; Dumont F; Tzanis D; Benhaim L; Malka D; Elias D
    Ann Surg Oncol; 2013 Feb; 20(2):491-6. PubMed ID: 22956066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of repeat cytoreductive surgery and heated intraperitoneal chemotherapy for patients with recurrent peritoneal carcinomatosis from appendiceal and colorectal cancers: a multicentre Canadian study.
    Jost E; Mack LA; Sideris L; Dube P; Temple W; Bouchard-Fortier A
    Can J Surg; 2020 Feb; 63(1):E71-E79. PubMed ID: 32080999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis.
    Hao Y; Liu Y; Ishibashi H; Wakama S; Nishino E; Yonemura Y
    Eur J Surg Oncol; 2019 Aug; 45(8):1493-1497. PubMed ID: 30948161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Braam HJ; van Oudheusden TR; de Hingh IH; Nienhuijs SW; Boerma D; Wiezer MJ; van Ramshorst B
    J Surg Oncol; 2014 Jun; 109(8):841-7. PubMed ID: 24619813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis.
    Klaver YL; Chua TC; de Hingh IH; Morris DL
    J Surg Oncol; 2012 Feb; 105(2):113-8. PubMed ID: 21780124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal-Free Cancer Cells Represent a Major Prognostic Factor in Colorectal Peritoneal Carcinomatosis.
    Trilling B; Cotte E; Vaudoyer D; Isaac S; Piaton E; Maurice C; Glehen O; Passot G
    Dis Colon Rectum; 2016 Jul; 59(7):615-22. PubMed ID: 27270513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in patients with synchronous peritoneal carcinomatosis (PC) caused by a primary cancer of the colon.
    Sadahiro S; Suzuki T; Maeda Y; Tanaka A; Makuuchi H; Kamijo A; Haruki Y; Murayama C
    J Gastrointest Surg; 2009 Sep; 13(9):1593-8. PubMed ID: 19488820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreduction and heated intraperitoneal chemotherapy for colorectal cancer: are we excluding patients who may benefit?
    Rivard JD; McConnell YJ; Temple WJ; Mack LA
    J Surg Oncol; 2014 Feb; 109(2):104-9. PubMed ID: 24449172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study.
    Burnett A; Lecompte MA; Trabulsi N; Dubé P; Gervais MK; Trilling B; Cloutier AS; Sideris L
    World J Surg Oncol; 2019 May; 17(1):83. PubMed ID: 31092250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases.
    Ripley RT; Davis JL; Kemp CD; Steinberg SM; Toomey MA; Avital I
    Trials; 2010 May; 11():62. PubMed ID: 20500867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
    Cashin PH; Graf W; Nygren P; Mahteme H
    Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: the experience of a tertiary Asian center.
    Teo MC; Ching Tan GH; Lim C; Chia CS; Tham CK; Soo KC
    Asian J Surg; 2015 Apr; 38(2):65-73. PubMed ID: 25059814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.
    Sugarbaker PH; Jablonski KA
    Ann Surg; 1995 Feb; 221(2):124-32. PubMed ID: 7857141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.
    Alzahrani NA; Valle SJ; Fisher OM; Sugarbaker PH; Yonemura Y; Glehen O; Goere D; Honore C; Brigand C; de Hingh I; Verwaal VJ; Deraco M; Baratti D; Kusamura S; Pocard M; Piso P; Maerz L; Marchal F; Moran B; Levine EA; Dumont F; Pezet D; Abboud K; Kozman MA; Liauw W; Morris DL;
    J Surg Oncol; 2019 Mar; 119(3):336-346. PubMed ID: 30554404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic features for peritoneal carcinomatosis in colorectal and appendiceal cancer patients when treated by cytoreductive surgery and intraperitoneal chemotherapy.
    Sugarbaker PH; Chang D; Koslowe P
    Cancer Treat Res; 1996; 81():89-104. PubMed ID: 8834578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.